• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

新型低剂量微粉化异维 A 酸 32 毫克制剂和利朵斯异维 A 酸 40 毫克在进食和禁食条件下的药代动力学比较:两项在健康成年参与者中进行的开放标签、随机、交叉研究。

Comparative Pharmacokinetic Profiles of a Novel Low-dose Micronized-isotretinoin 32 mg Formulation and Lidose-isotretinoin 40 mg in Fed and Fasted Conditions: Two Open-label, Randomized, Crossover Studies in Healthy Adult Participants.

机构信息

Research and Development Centre, Sun Pharmaceutical Industries Ltd, Gurgaon, Haryana, India.

出版信息

Acta Derm Venereol. 2020 Feb 5;100(4):adv00049. doi: 10.2340/00015555-3381.

DOI:10.2340/00015555-3381
PMID:31774544
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9128969/
Abstract

Two open-label, crossover studies compared the bioavailability of Micronized-isotretinoin 32 mg and Lidose-isotretinoin 40 mg in healthy adults. In the fed bioequivalence/food-effect study, participants (n = 71) received single doses of fed-state Micronized-isotretinoin 32 mg, fed-state Lidose-isotretinoin 40 mg and fasted-state Micronized-isotretinoin 32 mg. In the fasting study, participants (n = 18) received single doses of fasted-state Micronized-isotretinoin 32 mg and fasted-state Lidose-isotretinoin 40 mg. Bioavailability was assessed by isotretinoin LnAUC0–t, LnAUC0–∞ and LnCmax in blood samples taken pre-dosing and over 96 h post-dosing. The 90% confidence intervals for baseline-adjusted least squares geometric mean ratios for LnAUC0–t, LnAUC0–∞ and LnCmax fell within the 80–125% range for bioequivalence for fed-state Micronized-isotretinoin 32 mg vs. fed-state Lidose-isotretinoin 40 mg. Fasted-state Micronized-isotretinoin 32 mg had ~2 times higher bioavailability than fasted-state Lidose-isotretinoin 40 mg. Food had no effect on the rate and a marginal effect on the extent of absorption of Micronized-isotretinoin 32 mg.

摘要

两项开放性、交叉研究比较了健康成年人中单剂量 Micronized-isotretinoin(32mg)和 Lidose-isotretinoin(40mg)的生物利用度。在进食状态下的生物等效性/食物效应研究中,71 名参与者单次服用 Micronized-isotretinoin(32mg)、Lidose-isotretinoin(40mg)和 Micronized-isotretinoin(32mg)禁食状态。在禁食研究中,18 名参与者单次服用 Micronized-isotretinoin(32mg)和 Lidose-isotretinoin(40mg)禁食状态。通过测定血样中异维 A 酸 LnAUC0-t、LnAUC0-∞和 LnCmax 的浓度,评估生物利用度,这些血样是在给药前和给药后 96 小时内采集的。经基线调整的最小二乘几何均数比值的 90%置信区间,用于比较 Micronized-isotretinoin(32mg)进食状态与 Lidose-isotretinoin(40mg)进食状态的生物等效性,均落在 80%-125%范围内。与 Lidose-isotretinoin(40mg)禁食状态相比,Micronized-isotretinoin(32mg)禁食状态的生物利用度约高 2 倍。食物对 Micronized-isotretinoin(32mg)的吸收速率没有影响,但对吸收程度有轻微影响。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/32d9/9128969/ced1eaa08eaf/ActaDV-100-4-5644-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/32d9/9128969/ced1eaa08eaf/ActaDV-100-4-5644-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/32d9/9128969/ced1eaa08eaf/ActaDV-100-4-5644-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/32d9/9128969/ced1eaa08eaf/ActaDV-100-4-5644-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/32d9/9128969/ced1eaa08eaf/ActaDV-100-4-5644-g001.jpg

相似文献

1
Comparative Pharmacokinetic Profiles of a Novel Low-dose Micronized-isotretinoin 32 mg Formulation and Lidose-isotretinoin 40 mg in Fed and Fasted Conditions: Two Open-label, Randomized, Crossover Studies in Healthy Adult Participants.新型低剂量微粉化异维 A 酸 32 毫克制剂和利朵斯异维 A 酸 40 毫克在进食和禁食条件下的药代动力学比较:两项在健康成年参与者中进行的开放标签、随机、交叉研究。
Acta Derm Venereol. 2020 Feb 5;100(4):adv00049. doi: 10.2340/00015555-3381.
2
Enhancing Bioavailability: Advances in Oral Isotretinoin Formulations.提高生物利用度:口服异维 A 酸制剂的进展。
Skin Therapy Lett. 2024 Sep;29(5):10-12.
3
Improving bioavailability with a novel isotretinoin formulation (isotretinoin-Lidose).用新型异维A酸制剂(异维A酸-利多卡因)提高生物利用度。
Skin Therapy Lett. 2013 Sep-Oct;18(6):1-3.
4
Comparative pharmacokinetic profiles of a novel isotretinoin formulation (isotretinoin-Lidose) and the innovator isotretinoin formulation: a randomized, 4-treatment, crossover study.一种新型异维 A 酸制剂(异维 A 酸-利朵司)与原研异维 A 酸制剂的比较药代动力学特征:一项随机、4 治疗、交叉研究。
J Am Acad Dermatol. 2013 Nov;69(5):762-767. doi: 10.1016/j.jaad.2013.05.036. Epub 2013 Aug 13.
5
Safety of a new micronized formulation of isotretinoin in patients with severe recalcitrant nodular acne: A randomized trial comparing micronized isotretinoin with standard isotretinoin.异维A酸新微粉化制剂用于重度顽固性结节性痤疮患者的安全性:一项比较微粉化异维A酸与标准异维A酸的随机试验
J Am Acad Dermatol. 2001 Aug;45(2):196-207. doi: 10.1067/mjd.2001.115966.
6
Consensus Statements on the Use of Novel Formulations of Isotretinoin: A Modified Delphi Process.共识声明:新型异维 A 酸制剂的使用:改良 Delphi 法。
J Drugs Dermatol. 2024 Jun 1;23(6):429-432. doi: 10.36849/JDD.7971.
7
A randomized trial of the efficacy of a new micronized formulation versus a standard formulation of isotretinoin in patients with severe recalcitrant nodular acne.一项关于新的微粉化制剂与异维甲酸标准制剂治疗重度顽固性结节性痤疮疗效的随机试验。
J Am Acad Dermatol. 2001 Aug;45(2):187-95. doi: 10.1067/mjd.2001.115965.
8
ARTICLE: Advances in Oral Isotretinoin Therapy.文章:口服异维 A 酸治疗的进展。
J Drugs Dermatol. 2021 May 1;20(5):s5-s11. doi: 10.36849/JDD.s072A.
9
Bioequivalence of two quetiapine extended release tablets in Chinese healthy volunteers under fasting and fed conditions and effects of food on pharmacokinetic profiles.两种喹硫平缓释片在中国健康志愿者空腹及进食条件下的生物等效性以及食物对药代动力学特征的影响。
Drug Des Devel Ther. 2018 Dec 31;13:255-264. doi: 10.2147/DDDT.S182965. eCollection 2019.
10
A Phase I, Randomized, Crossover, Open-label Study of the Pharmacokinetics of Solriamfetol (JZP-110) in Healthy Adult Subjects With and Without Food.一项在有/无食物的健康成年受试者中研究索里昂(JZP-110)药代动力学的 I 期、随机、交叉、开放标签研究。
Clin Ther. 2019 Feb;41(2):196-204. doi: 10.1016/j.clinthera.2018.12.001. Epub 2018 Dec 28.

引用本文的文献

1
Pharmacokinetic Simulation and Area under the Curve Estimation of Drugs Subject to Enterohepatic Circulation.肠肝循环药物的药代动力学模拟及曲线下面积估计
Pharmaceutics. 2024 Aug 6;16(8):1044. doi: 10.3390/pharmaceutics16081044.
2
Retinoid Therapy for Neuroblastoma: Historical Overview, Regulatory Challenges, and Prospects.用于神经母细胞瘤的维甲酸疗法:历史概述、监管挑战与前景
Cancers (Basel). 2024 Jan 26;16(3):544. doi: 10.3390/cancers16030544.
3
Rationale for Use of Micronized Isotretinoin for Treatment of Acne Vulgaris: Practical Considerations and Therapeutic Advantages.

本文引用的文献

1
Comparative pharmacokinetic profiles of a novel isotretinoin formulation (isotretinoin-Lidose) and the innovator isotretinoin formulation: a randomized, 4-treatment, crossover study.一种新型异维 A 酸制剂(异维 A 酸-利朵司)与原研异维 A 酸制剂的比较药代动力学特征:一项随机、4 治疗、交叉研究。
J Am Acad Dermatol. 2013 Nov;69(5):762-767. doi: 10.1016/j.jaad.2013.05.036. Epub 2013 Aug 13.
2
Work hours and perceived time barriers to healthful eating among young adults.年轻人的工作时间以及对健康饮食存在的时间障碍认知
Am J Health Behav. 2012 Nov;36(6):786-96. doi: 10.5993/AJHB.36.6.6.
3
Do breakfast skipping and breakfast type affect energy intake, nutrient intake, nutrient adequacy, and diet quality in young adults? NHANES 1999-2002.
使用微粉化异维A酸治疗寻常痤疮的理论依据:实际考量与治疗优势
J Clin Aesthet Dermatol. 2023 Sep;16(9):20-24.
4
Oral Isotretinoin and Its Uses in Dermatology: A Review.口服异维 A 酸及其在皮肤科的应用:综述。
Drug Des Devel Ther. 2023 Aug 25;17:2573-2591. doi: 10.2147/DDDT.S427530. eCollection 2023.
5
New Formulations of Isotretinoin for Acne Treatment: Expanded Options and Clinical Implications.用于痤疮治疗的异维A酸新制剂:拓展的选择及临床意义
J Clin Aesthet Dermatol. 2021 Dec;14(12 Suppl 1):S18-S23.
不吃早餐和早餐类型会影响年轻人的能量摄入、营养素摄入、营养素充足程度和饮食质量吗?NHANES 1999-2002。
J Am Coll Nutr. 2010 Aug;29(4):407-18. doi: 10.1080/07315724.2010.10719858.
4
Management of acne vulgaris: an evidence-based update.寻常痤疮的治疗:基于证据的更新。
Clin Exp Dermatol. 2010 Jun;35(4):351-4. doi: 10.1111/j.1365-2230.2009.03683.x. Epub 2009 Oct 23.
5
Profile of acne patients in the Philippines requiring a second course of oral isotretinoin.菲律宾需要第二疗程口服异维甲酸的痤疮患者概况。
Int J Dermatol. 2005 Dec;44(12):999-1001. doi: 10.1111/j.1365-4632.2005.02284.x.
6
Isotretinoin for acne vulgaris--10 years later: a safe and successful treatment.异维A酸治疗寻常痤疮——10年后:一种安全且成功的治疗方法。
Br J Dermatol. 1993 Sep;129(3):292-6. doi: 10.1111/j.1365-2133.1993.tb11849.x.
7
Food increases the bioavailability of isotretinoin.食物可提高异维A酸的生物利用度。
J Clin Pharmacol. 1983 Nov-Dec;23(11-12):534-9. doi: 10.1002/j.1552-4604.1983.tb01800.x.
8
Isotretinoin therapy for acne: results of a multicenter dose-response study.异维A酸治疗痤疮:一项多中心剂量反应研究的结果
J Am Acad Dermatol. 1984 Mar;10(3):490-6. doi: 10.1016/s0190-9622(84)80100-0.